ClinicalTrials.gg
CompletedNCT07486466Updated Sep 2, 2026

ACL Mechanical Property Changes in Female Collegiate Basketball Players During a Competitive Season

An observational study in Female Athletes, Anterior Cruciate Ligament Injuries and Athletic Performance, sponsored by Fu Jen Catholic University Hospital. Completed at 1 site in Taiwan. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Fu Jen Catholic University Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This prospective cohort study aims to investigate whether the mechanical properties of the anterior cruciate ligament (ACL) undergo measurable changes throughout a competitive basketball season in female collegiate athletes. Female athletes are at a significantly higher risk for non-contact ACL injuries compared to males. Beyond acute injuries, cumulative stress from high-intensity sports may lead to subclinical alterations in the ligament's biomechanical properties, potentially increasing injury risk.

Using non-invasive shear wave elastography (SWE) and countermovement jump (CMJ) tests, the study will monitor 60 elite players before and after the University Basketball League (UBL) season. The findings will help identify potential signs of cumulative loading and contribute to the development of early detection markers for injury risk in female athletes.

Read the detailed description

[Introduction and Rationale] The anterior cruciate ligament (ACL) is a critical stabilizer of the knee joint, particularly during high-demand athletic activities involving pivoting, rapid deceleration, and landing. Female athletes exhibit a significantly higher incidence (2 to 9 times) of non-contact ACL injuries compared to their male counterparts. While acute trauma is a well-recognized mechanism, emerging evidence suggests that cumulative loading over a competitive season may lead to subclinical alterations in the ligament's mechanical properties. These changes, such as decreased stiffness, may predispose athletes to injury by compromising joint stability and neuromuscular control. However, objective in vivo data regarding the seasonal adaptation of the ACL in elite athletes remains sparse.

[Study Design and Participants] This prospective cohort study will recruit 60 elite female collegiate basketball players from Division I teams of the University Basketball Association (UBA). The research is designed to track longitudinal changes in ACL integrity and functional performance across a full competitive season.

[Study Procedures]

Participants will undergo standardized assessments at two distinct time points:

Pre-season Assessment (Baseline): Conducted in October, prior to the start of the competitive UBL season.

Post-season Assessment: Conducted in April, following the conclusion of the competitive basketball season.

During each session, two primary modalities will be employed:

  1. Imaging-based Assessment (Shear Wave Elastography):

    Shear Wave Elastography (SWE) will be utilized to non-invasively quantify the mechanical properties of the ACL. The assessment will focus on:

    Shear Wave Speed (m/s) Shear Modulus (kPa) These metrics serve as direct indicators of tissue stiffness and structural integrity. Measurements will be taken with the knee in a consistent, standardized position to ensure reproducibility.

  2. Functional Biomechanical Performance (Countermovement Jump):

Participants will perform Countermovement Jumps (CMJ) on KFORCE force plates to evaluate lower limb dynamic performance. This functional test provides insight into the athlete's neuromuscular status. Key variables collected will include:

Jump Height (cm) Reactive Strength Index (RSI): Calculated as the ratio of jump height to ground contact time.

Force Metrics: Including eccentric and concentric impulse to analyze force production and absorption strategies.

[Research Goal] By integrating imaging-based mechanical data with functional biomechanical outcomes, this study seeks to identify potential "fatigue" markers or adaptive responses in the ACL resulting from seasonal athletic demands. The findings aim to bridge the gap between clinical imaging and athletic performance, ultimately informing individualized injury prevention strategies and early detection protocols for female athletes at risk.

02

Conditions studied

  • Female Athletes
  • Anterior Cruciate Ligament Injuries
  • Athletic Performance
  • Sports Injuries
  • Biomechanical Phenomena

Keywords

  • ACL injuries
  • female basketball players
  • shear wave elastography
  • biomechanical variable
03

In context

Anterior Cruciate Ligament Injuries

625 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 192 are open to participants now.

This study's enrollment of 60 is below the median of 98 across 153 observational studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

Fu Jen Catholic University Hospital is the lead sponsor of 33 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Elite female collegiate basketball teams

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female collegiate basketball players currently active in Division I
  • Aged between 18 and 35 years
  • At least 5 years of formal basketball training experience
  • No prior history of anterior cruciate ligament (ACL) rupture in either knee
  • Ability to participate in both pre-season and post-season testing sessions

Exclusion criteria

Exclusion Criteria:

  • Lower limb injury during the study period resulting in interruption of training for one month or longer
  • Bilateral knee surgery for any reason during the course of the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. ACL Shear Modulus

    The shear modulus of the anterior cruciate ligament (ACL) will be measured using shear wave elastography (SWE). This value serves as a quantitative indicator of ligament tissue stiffness.

    Time frame: Baseline and at the end of the competitive season (approximately 6 months)

  2. ACL Shear Wave Speed

    The velocity of shear waves propagating through the ACL tissue, measured via SWE. This value is used to evaluate the structural integrity and density of the ligament tissue.

    Time frame: Baseline and at the end of the competitive season (approximately 6 months)

  3. Reactive Strength Index (RSI)

    Calculated as the ratio of jump height to ground contact time (RSI = jump height / ground contact time) during a countermovement jump (CMJ). This index evaluates the explosive power and neuromuscular control of the lower limbs.

    Time frame: Baseline and at the end of the competitive season (approximately 6 months)

  4. Countermovement Jump (CMJ) Height

    The maximum vertical displacement of the center of mass during a countermovement jump, measured using KFORCE force plates.

    Time frame: Baseline and at the end of the competitive season (approximately 6 months)

07

Study locations

1 site
  • FJUH Institutional Review Board
    New Taipei City, Taishan District 243, Taiwan
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Apr 2026, 7 months.

Of 73 non-industry observational studies under Anterior Cruciate Ligament Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 167. This study's 7 months is below that.

Counting every sponsor, half of 82 studies reached it within 37 months; a quarter within 13 and three quarters within 76.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2026
First posted
Mar 20, 2026
StartActual
Sep 30, 2025
Primary completionActual
Apr 30, 2026
CompletionActual
Jul 30, 2026
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07486466
Lead sponsor
Fu Jen Catholic University Hospital
Responsible party
Sponsor
First posted
Mar 20, 2026
Start date
Sep 30, 2025
Primary completion
Apr 30, 2026
Completion
Jul 30, 2026
Last update
Sep 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion